On Thursday, Prince Harry took bioLytical’s 60-second INSTI HIV antibody test at London-based Guy and St. Thomas’ Hospital during a live broadcasting on the royal family’s Facebook page.
The Canadian-based company’s INSTI test produces results with 99 percent accuracy, requiring a single drop of blood from the patient. The test will be available online and in various retail locations by the end of the year, offering patients the opportunity to complete the test in the comfort of their own homes.
“Prince Harry believes until everyone feels relaxed about taking HIV tests — whether from high risk groups or not — then tackling the stigma and fear surrounding HIV testing will continue to allow the virus to win,” according to a statement from Kensington Palace.
Prince Harry’s test results were negative.
More articles on supply chain:
5 latest FDA approvals
Drugmakers have firm grasp on drug pricing power
Drug shortages force workarounds in Conn. hospitals
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
